{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:31:13Z","timestamp":1790109073815,"version":"4.0.1"},"reference-count":91,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","award":["2021\/10078-3"],"award-info":[{"award-number":["2021\/10078-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Women with prolactinoma are usually infertile but can conceive after surgery or treatment with dopamine agonists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the impact of pregnancy in prolactinoma's natural course and in maternal\u2013fetal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources<\/jats:title>\n                    <jats:p>MEDLINE, EMBASE, LILACS, and CENTRAL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection<\/jats:title>\n                    <jats:p>Observational studies that included at least 3 pregnant women with prolactinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Extraction<\/jats:title>\n                    <jats:p>Two independent reviewers selected studies, assessed the risk of bias, and extracted data from the included studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis<\/jats:title>\n                    <jats:p>Fifty-two studies were included, involving 2544 pregnancies in 1928 women. Stata Statistical Software 18 was used for proportional meta-analyses. The overall frequency of pregnant women on dopamine agonist treatment at conception was 97% and for either continuing or resuming treatment during pregnancy was 6%. The overall frequency of miscarriage was 10% (95% CI, 8-12), 3% for prematurity (95% CI, 2-5), 4% for symptomatic tumor growth during pregnancy (95% CI, 2-8), 4% for visual impairment (95% CI, 2-7), 6% for headache (95% CI, 4-9), and 4% for development of gestational diabetes (95% CI, 3-7). The overall frequency of congenital malformations was 2% (95% CI, 1-4), 2% for perinatal mortality (95% CI, 1-2), and 6% for low birth weight (95% CI, 3-9). Moreover, prolactinoma's size is a significant modifier for visual impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pregnancy in women with prolactinoma is safe in relation to fetal and maternal outcomes with low frequencies of miscarriage, prematurity, symptomatic growth, visual impairment, headache, congenital malformations, perinatal mortality, and low birth weight.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae821","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T15:19:35Z","timestamp":1732375175000},"page":"e1241-e1251","source":"Crossref","is-referenced-by-count":8,"title":["Disease Activity and Maternal\u2013fetal Outcomes in Pregnant Women With Prolactinoma: A Systematic Review and Meta-analysis"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2887-1475","authenticated-orcid":false,"given":"Diego Barata","family":"Bandeira","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, S\u00e3o Paulo State University (UNESP), Medical School , Botucatu, S\u00e3o Paulo 18618-687 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-1140","authenticated-orcid":false,"given":"Let\u00edcia Santana","family":"Alves","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, S\u00e3o Paulo State University (UNESP), Medical School , Botucatu, S\u00e3o Paulo 18618-687 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8201-6756","authenticated-orcid":false,"given":"Andrea","family":"Glezer","sequence":"additional","affiliation":[{"name":"Neuroendocrine Unit, Division of Endocrinology and Metabolism, Hospital das Cl\u00ednicas, University of Sao Paulo Medical School , S\u00e3o Paulo 05403-010 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar Luiz","family":"Boguszewski","sequence":"additional","affiliation":[{"name":"Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana , Curitiba 80030-110 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-4167","authenticated-orcid":false,"given":"Vania","family":"dos Santos Nunes-Nogueira","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, S\u00e3o Paulo State University (UNESP), Medical School , Botucatu, S\u00e3o Paulo 18618-687 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"issue":"2","key":"2026041420192283400_dgae821-B1","doi-asserted-by":"crossref","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of prolactinomas: the old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"12","key":"2026041420192283400_dgae821-B2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/jne.12223","article-title":"Prolactin regulation of kisspeptin neurones in the mouse brain and its role in the lactation-induced suppression of kisspeptin expression","volume":"26","author":"Brown","year":"2014","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"2026041420192283400_dgae821-B3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ando.2016.04.001","article-title":"Prolactinoma and pregnancy: from the wish of conception to lactation","volume":"77","author":"Maiter","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"2026041420192283400_dgae821-B4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11060-010-0326-2","article-title":"Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line","volume":"102","author":"Lv","year":"2011","journal-title":"J Neurooncol"},{"issue":"4","key":"2026041420192283400_dgae821-B5","first-page":"491","article-title":"Impaired pituitary response to bromocriptine suppression: reversal after bromocriptine plus tamoxifen","volume":"101","author":"V\u00f6lker","year":"1982","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"7","key":"2026041420192283400_dgae821-B6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4158\/EP-2018-0321","article-title":"THE EFFECT OF RALOXIFENE ON SERUM PROLACTIN LEVEL IN PATIENTS WITH PROLACTINOMA","volume":"25","author":"Choudhary","year":"2019","journal-title":"Endocr Pract"},{"issue":"3","key":"2026041420192283400_dgae821-B7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s12020-013-9931-0","article-title":"Evaluation of body weight, insulin resistance, leptin and adiponectin levels in premenopausal women with hyperprolactinemia","volume":"44","author":"Atmaca","year":"2013","journal-title":"Endocrine"},{"issue":"3","key":"2026041420192283400_dgae821-B8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder","year":"2011","journal-title":"Pituitary"},{"key":"2026041420192283400_dgae821-B9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fendo.2020.00083","article-title":"Plasma prolactin and progesterone levels and the risk of gestational diabetes: a prospective and longitudinal study in a multiracial cohort","volume":"11","author":"Li","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2026041420192283400_dgae821-B10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a pituitary society international consensus statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"2026041420192283400_dgae821-B11","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1530\/EJE-14-0848","article-title":"Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma","volume":"172","author":"Molitch","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026041420192283400_dgae821-B12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11102-010-0290-z","article-title":"Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis","volume":"14","author":"dos Santos Nunes","year":"2011","journal-title":"Pituitary"},{"issue":"2","key":"2026041420192283400_dgae821-B13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11102-019-01008-z","article-title":"A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas","volume":"23","author":"Sant\u2019 Anna","year":"2020","journal-title":"Pituitary"},{"key":"2026041420192283400_dgae821-B14","first-page":"252","volume-title":"JBI Manual for Evidence Synthesis","author":"Moola","year":"2024"},{"key":"2026041420192283400_dgae821-B15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2026041420192283400_dgae821-B16","first-page":"7","article-title":"Prolactinoma and pregnancy: a study protocol","volume":"16","author":"Diego Barata Bandeira","year":"2022","journal-title":"Asian J Adv Res Rep"},{"key":"2026041420192283400_dgae821-B17","author":"Diego Barata Bandeira"},{"issue":"1","key":"2026041420192283400_dgae821-B18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"10","key":"2026041420192283400_dgae821-B19","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"1","key":"2026041420192283400_dgae821-B20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"issue":"4","key":"2026041420192283400_dgae821-B21","first-page":"27","article-title":"Meta-regression in stata","volume":"8","author":"Roger","year":"2008","journal-title":"Stata J"},{"issue":"1","key":"2026041420192283400_dgae821-B22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"issue":"7","key":"2026041420192283400_dgae821-B23","doi-asserted-by":"crossref","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"2026041420192283400_dgae821-B24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"269","key":"2026041420192283400_dgae821-B25","first-page":"58","article-title":"Pregnancy in patients with prolactinomas","volume":"41","author":"Ferrer-Barriendos","year":"1982","journal-title":"Rev Esp Obstet Ginecol"},{"issue":"1","key":"2026041420192283400_dgae821-B26","first-page":"63","article-title":"Pituitary microprolactinoma, bromocriptine, and pregnancy: follow-up of 74 cases","volume":"42","author":"Omodei","year":"1987","journal-title":"Curr Ther Res Clin Exp"},{"issue":"10","key":"2026041420192283400_dgae821-B27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1055\/s-0043-112861","article-title":"Pregnancy and tumor outcomes in women with prolactinoma","volume":"125","author":"Araujo","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"5","key":"2026041420192283400_dgae821-B28","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12370","article-title":"Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients","volume":"80","author":"Domingue","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026041420192283400_dgae821-B29","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3171\/jns.1983.58.5.0685","article-title":"Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors","volume":"58","author":"Laws","year":"1983","journal-title":"J Neurosurg"},{"issue":"6","key":"2026041420192283400_dgae821-B30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0015-0282(16)45552-4","article-title":"Surgical treatment of pituitary prolactinomas: postoperative prolactin and fertility in seventy patients","volume":"35","author":"Landolt","year":"1981","journal-title":"Fertil Steril"},{"issue":"2","key":"2026041420192283400_dgae821-B31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2265.2010.03808.x","article-title":"Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women","volume":"73","author":"Lebbe","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026041420192283400_dgae821-B32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4103\/ijem.ijem_372_21","article-title":"Prolactinoma outcome after pregnancy and lactation: a cohort study","volume":"25","author":"Laway","year":"2021","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"2026041420192283400_dgae821-B33","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1210\/jc.2009-2605","article-title":"Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas","volume":"95","author":"Ono","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026041420192283400_dgae821-B34","first-page":"6","article-title":"Prolactinoma and gestation: a reality","volume":"4","author":"Erika","year":"2018","journal-title":"Crit Care Obstet Gynecol"},{"issue":"4","key":"2026041420192283400_dgae821-B35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/09513590.2016.1254177","article-title":"Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy","volume":"33","author":"Rastogi","year":"2017","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2026041420192283400_dgae821-B36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0028-2243(81)90031-9","article-title":"Conservative management of suspected prolactin secreting pituitary adenoma during pregnancy","volume":"11","author":"Weinstein","year":"1981","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"2026041420192283400_dgae821-B37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0015-0282(16)45977-7","article-title":"Prolactin-secreting pituitary adenomas: neurosurgical management of 37 patients","volume":"37","author":"Woosley","year":"1982","journal-title":"Fertil Steril"},{"issue":"1","key":"2026041420192283400_dgae821-B38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11102-005-5083-4","article-title":"Prolactinomas and pregnancy","volume":"8","author":"Bronstein","year":"2005","journal-title":"Pituitary"},{"issue":"3","key":"2026041420192283400_dgae821-B39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/ajo.13070","article-title":"An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists","volume":"60","author":"O'Sullivan","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"2026041420192283400_dgae821-B40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0015-0282(16)45806-1","article-title":"Bromocriptine as prophylactic therapy in prolactinoma during pregnancy","volume":"36","author":"Canales","year":"1981","journal-title":"Fertil Steril"},{"issue":"3","key":"2026041420192283400_dgae821-B41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0015-0282(16)55250-9","article-title":"Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies","volume":"58","author":"Ahmed","year":"1992","journal-title":"Fertil Steril"},{"issue":"8","key":"2026041420192283400_dgae821-B42","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/oxfordjournals.humrep.a137010","article-title":"Is pregnancy the best treatment for hyperprolactinaemia?","volume":"4","author":"Crosignani","year":"1989","journal-title":"Hum Reprod"},{"issue":"8","key":"2026041420192283400_dgae821-B43","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0002-9378(83)90968-7","article-title":"Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas","volume":"146","author":"Konopka","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2026041420192283400_dgae821-B44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40618-017-0709-8","article-title":"How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey","volume":"41","author":"Karaca","year":"2018","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2026041420192283400_dgae821-B45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/01443615.2016.1233946","article-title":"Prolactinoma and pregnancy\u2013a series of cases including pituitary apoplexy","volume":"37","author":"Galv\u00e3o","year":"2017","journal-title":"J Obstet Gynaecology"},{"issue":"1","key":"2026041420192283400_dgae821-B46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/jc.2012-3039","article-title":"Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation","volume":"98","author":"Auriemma","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6117","key":"2026041420192283400_dgae821-B47","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/bmj.1.6117.875","article-title":"Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors","volume":"1","author":"Bergh","year":"1978","journal-title":"Br Med J"},{"issue":"7","key":"2026041420192283400_dgae821-B48","first-page":"343","article-title":"[Use of bromocriptine during pregnancy and appearance of partial empty sella turcica in women with prolactinoma]","volume":"189","author":"L\u00f3pez de la Torre Casares","year":"1991","journal-title":"Rev Clin Esp"},{"issue":"6","key":"2026041420192283400_dgae821-B49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0015-0282(16)44050-1","article-title":"The inscidence of complications during pregnancy after treatment of hyperprolactinemia with bromocriptine in patients with radiologically evident pituitary tumors","volume":"31","author":"Lamberts","year":"1979","journal-title":"Fertil Steril"},{"issue":"5","key":"2026041420192283400_dgae821-B50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/cen.14162","article-title":"Evolution of macroprolactinomas during pregnancy: a cohort study of 85 pregnancies","volume":"92","author":"Barraud","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2026041420192283400_dgae821-B51","first-page":"610","article-title":"Pregnancy in hyperprolactinemic patients","volume":"118","author":"Ventz","year":"1996","journal-title":"Zentralbl Gynakol"},{"issue":"4","key":"2026041420192283400_dgae821-B52","first-page":"229","article-title":"Prolactinoma and pregnancy: a retrospective study of 24 cases","volume":"98","author":"Wehba","year":"1988","journal-title":"J Bras Ginecol"},{"issue":"4","key":"2026041420192283400_dgae821-B53","first-page":"806","article-title":"Fertility in prolactinomas\u2013considerations concerning some clinical cases","volume":"105","author":"Ionescu","year":"2001","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"issue":"4","key":"2026041420192283400_dgae821-B54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/eje.0.1350413","article-title":"Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy","volume":"135","author":"Morange","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2026041420192283400_dgae821-B55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1479-828X.1990.tb03228.x","article-title":"Long-term radiographic follow-up of the sella turcica in hyperprolactinaemic women","volume":"30","author":"Rasmussen","year":"1990","journal-title":"Aust N Z J Obstet Gynaecol."},{"issue":"4","key":"2026041420192283400_dgae821-B56","first-page":"140","article-title":"Macroprolactinomas and pregnancy","volume":"55","author":"Trejbalova","year":"2006","journal-title":"Lek Obz"},{"issue":"6","key":"2026041420192283400_dgae821-B57","first-page":"708","article-title":"Spontaneous and induced pregnancies in hyperprolactinemic women","volume":"58","author":"Crosignani","year":"1981","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2026041420192283400_dgae821-B58","first-page":"407","article-title":"The effect of pregnancy and lactation on pituitary prolactin-secreting tumours","volume":"92","author":"Zarate","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"6193","key":"2026041420192283400_dgae821-B59","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/bmj.2.6193.771","article-title":"Pregnancy in patients presenting with hyperprolactinaemia","volume":"2","author":"Thorner","year":"6193","journal-title":"Br Med J"},{"issue":"4","key":"2026041420192283400_dgae821-B60","first-page":"425","article-title":"Prolactin-producing microadenomas in pregnancy","volume":"62","author":"Divers","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2026041420192283400_dgae821-B61","first-page":"25","article-title":"Retrospective study of any potencial adverse effects of cabergoline on pregnancy and embryofetal development","volume":"47","author":"Stalldecker","year":"2010","journal-title":"Rev Argent Endocrinol Metab"},{"issue":"2","key":"2026041420192283400_dgae821-B62","first-page":"108","article-title":"Hyperprolactinemia and pregnancy. Clinical series","volume":"10","author":"Gangemi","year":"1983","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"4","key":"2026041420192283400_dgae821-B63","first-page":"452","article-title":"Women with prolactinoma\u2014effect of pregnancy and lactation on serum prolactin and on tumour growth","volume":"111","author":"Holmgren","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"40","key":"2026041420192283400_dgae821-B64","first-page":"2117","article-title":"Is pregnancy a cure for prolactin-secreting pituitary adenoma? Eighteen cases","volume":"17","author":"Bricaire","year":"1988","journal-title":"Presse Medicale"},{"issue":"3","key":"2026041420192283400_dgae821-B65","first-page":"259","article-title":"Influence of pregnancy on the serum prolactin level following prolactinoma surgery","volume":"125","author":"Hirohata","year":"1991","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2026041420192283400_dgae821-B66","first-page":"35","article-title":"The effect of pregnancy and lactation on prolactinoma","volume":"35","author":"Kim","year":"2014","journal-title":"Endocr Rev"},{"issue":"10","key":"2026041420192283400_dgae821-B67","first-page":"821","article-title":"Pregnancy-induced changes in prolactinomas as assessed with computed tomography","volume":"33","author":"Toffle","year":"1988","journal-title":"J Reprod Med"},{"issue":"7","key":"2026041420192283400_dgae821-B68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/0003-4819-121-7-199410010-00001","article-title":"Visual loss in pregnant women with pituitary adenomas","volume":"121","author":"Kupersmith","year":"1994","journal-title":"Ann Intern Med"},{"issue":"6","key":"2026041420192283400_dgae821-B69","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/a-1468-4608","article-title":"Outcomes of patients with macroprolactinoma desiring pregnancy: follow-up to 23 years from a single center","volume":"53","author":"Tanrikulu","year":"2021","journal-title":"Horm Metab Res"},{"issue":"1","key":"2026041420192283400_dgae821-B70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/AOG.0000000000001747","article-title":"Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes","volume":"129","author":"Lambert","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2026041420192283400_dgae821-B71","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1471-0528.1984.tb15076.x","article-title":"Prophylactic bromocriptine treatment during pregnancy in women with macroprolactinomas: report of 13 pregnancies","volume":"91","author":"De Wit","year":"1984","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"2","key":"2026041420192283400_dgae821-B72","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9378(83)90108-4","article-title":"The outcome of pregnancy in patients with treated and untreated prolactin-secreting pituitary tumors","volume":"147","author":"Hammond","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2026041420192283400_dgae821-B73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000299003","article-title":"Spontaneous pregnancies in hyperprolactinemic women","volume":"19","author":"Crosignani","year":"1985","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"2026041420192283400_dgae821-B74","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.1982.tb01636.x","article-title":"Bromocriptine-induced pregnancies in women with large prolactinomas","volume":"17","author":"Bergh","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026041420192283400_dgae821-B75","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1471-0528.1986.tb08660.x","article-title":"Fertility and pregnancy after operation for a prolactinoma","volume":"93","author":"Richards","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"2026041420192283400_dgae821-B76","first-page":"1","article-title":"Perinatal mortality in the United States, 2020-2021","volume":"489","author":"Valenzuela","year":"2023","journal-title":"NCHS Data Brief"},{"issue":"1","key":"2026041420192283400_dgae821-B77","doi-asserted-by":"crossref","first-page":"e00003121","DOI":"10.1590\/0102-311x00003121","article-title":"Perinatal mortality in Brazil in 2018: an epidemiological analysis according to the modified wigglesworth classification","volume":"38","author":"Nobrega","year":"2022","journal-title":"Cad Saude Publica"},{"issue":"1","key":"2026041420192283400_dgae821-B78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5334\/aogh.2348","article-title":"Perinatal mortality in sub-saharan Africa: a meta-analysis of demographic and health surveys","volume":"85","author":"Akombi","year":"2019","journal-title":"Ann Glob Health"},{"issue":"1","key":"2026041420192283400_dgae821-B79","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1186\/s12889-020-08925-w","article-title":"Decreasing trend in preterm birth and perinatal mortality, do disparities also decline?","volume":"20","author":"Ravelli","year":"2020","journal-title":"BMC Public Health"},{"issue":"7","key":"2026041420192283400_dgae821-B80","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1016\/S2214-109X(18)30565-5","article-title":"National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis","volume":"7","author":"Blencowe","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2026041420192283400_dgae821-B81","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-90-481-9485-8_20","article-title":"The prevalence of congenital anomalies in Europe","volume":"686","author":"Dolk","year":"2010","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2026041420192283400_dgae821-B82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ijgo.13195","article-title":"Global burden of preterm birth","volume":"150","author":"Walani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"issue":"10285","key":"2026041420192283400_dgae821-B83","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"2026041420192283400_dgae821-B84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ppe.12417","article-title":"Trends in risk of pregnancy loss among US women, 1990-2011","volume":"32","author":"Rossen","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"1","key":"2026041420192283400_dgae821-B85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12978-016-0181-5","article-title":"Trends in ectopic pregnancy, hydatidiform mole and miscarriage in the largest obstetrics and gynaecology hospital in China from 2003 to 2013","volume":"13","author":"Li","year":"2016","journal-title":"Reprod Health"},{"issue":"11","key":"2026041420192283400_dgae821-B86","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/aogs.13210","article-title":"Is the incidence of recurrent pregnancy loss increasing? A retrospective register-based study in Sweden","volume":"96","author":"Rasmark Roepke","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"11","key":"2026041420192283400_dgae821-B87","first-page":"2120","article-title":"Trends in the incidence, rate and treatment of miscarriage-nationwide register-study in Finland, 1998-2016","volume":"34","author":"Linnakaari","year":"2019","journal-title":"Hum Reprod"},{"issue":"5","key":"2026041420192283400_dgae821-B88","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/jdi.12634","article-title":"Higher maternal serum prolactin levels are associated with reduced glucose tolerance during pregnancy","volume":"8","author":"Ekinci","year":"2017","journal-title":"J Diabetes Investig"},{"issue":"7","key":"2026041420192283400_dgae821-B89","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/dc16-0043","article-title":"Maternal Serum prolactin and prediction of postpartum \u03b2-cell function and risk of prediabetes\/diabetes","volume":"39","author":"Retnakaran","year":"2016","journal-title":"Diabetes Care"},{"key":"2026041420192283400_dgae821-B90","author":"Deeks"},{"issue":"1","key":"2026041420192283400_dgae821-B91","first-page":"e12417","article-title":"A 21st century epidemy-obesity: and its impact on pregnancy loss","volume":"13","author":"Malasevskaia","year":"2021","journal-title":"Cureus"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae821\/61086114\/dgae821.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/e1241\/61086114\/dgae821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/e1241\/61086114\/dgae821.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:38:24Z","timestamp":1776213504000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/4\/e1241\/7908152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":91,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,11,25]]},"published-print":{"date-parts":[[2025,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae821","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,11,25]]}}}